EU-funded project AGePOP receives 2.8 million euro to train young researchers to provide safe and effective oral drugs for geriatric patients and older people. 13 organisations from 5 European countries, with leading experts in oral drug absorption and development, clinical research and practice, mentoring and training collaborate to revolutionise drug formulation, to benefit society as a whole.

11 Early Stage Researchers will be trained in a multisectoral approach to become the future experts in drug development for the advanced age population, shedding a much needed light on the needs of our ageing society. During the project and beyond, they will boost Europe’s innovation capacity and leadership in oral drug development.